Close Menu

NEW YORK – Enzo Biochem reported after the close of the market on Thursday that revenues for its fiscal second quarter ticked up less than 1 percent year over year, as the Protecting Access to Medicare Act (PAMA) continued to negatively affect reimbursements from Medicare and third-party payers.

For the three months ended Jan. 31, the diagnostics company reported total revenues of $19.4 million, compared to $19.3 million in the year-ago quarter.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US has sent its formal notice of withdrawal from the World Health Organization, according to the Wall Street Journal.

Science reports that a draft spending bill would increase the US National Institutes of Health budget by 13 percent.

The Harvard Crimson reports that Harvard and MIT are suing the Department of Homeland Security and ICE over the new international student visa policy.

In Nucleic Acids Research this week: algorithm to determine molecular sequence types and other microbial features, computational method to uncover R-loop structures, and more.